Exosome Diagnostics is developing biofluid-based molecular diagnostic tests for use in personalized medicine. Exosomes and other microvesicles are shed into all biofluids, including blood, urine and cerebrospinal fluid, forming a highly enriched source of intact, disease-specific nucleic acids. The Company's proprietary exosome technologymakes use of this natural enrichment to achieve high sensitivity and specificity for rare gene transcripts and the expression of genes responsible for cancers and other diseases.

Biotechnology

Health Care

Health Diagnostics

Exosome Diagnostics

Benjamin Sawicki

Chelsea S.

Hilary Graham Ph.D.

Dan Baughman

Matthew Dindinger

Johan Skog

Kelli Neary

Jason M Alter

Kaitlyn Xavier

Mark Cate

Lorinda Hedstrom

Hannah Soulard

Brian Raifsnider

Katelyn Silk

Kimberly Altschuler

Chris Bentis

Frances Perez

Krishna Champaneria

The Engineering and Quality Assurance team at Exosome Diagnostics specializes in developing and maintaining the technological systems that process biofluid samples and ensure the accuracy and reliability of molecular diagnostic tests. They integrate advanced software solutions and automation to optimize workflows and employ rigorous quality assurance practices to meet regulatory standards, thereby enhancing the sensitivity and specificity of diagnostic results.

Engineering and Quality Assurance

Sales and Account Management

Research and Development

Engineering and Quality Assurance

About

Team members

Other teams at Exosome Diagnostics

Sales and Account Management

Research and Development